Example: bankruptcy
APPENDIX ONE RECKONABLE SERVICE GUIDANCE
Special Health Boards Wales: NHS Trusts Local Health Boards and any predecessor or successor of the above organisations. 2 Additional Recognised Organisations. ... guidance should be sought to confirm whether a role is deemed to be highly relevant.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
North Yorkshire and York Menopause Guidance HRT (refer to ...
northyorkshireccg.nhs.ukLevonorgestrel (Mirena) device In an HRT regime, it has a 4-year license. FSRH state it can be used for 5 years for endometrial protection (note offlabel) 2nd Line Estraderm MX patches. 25, 50, 75, 100mcg estradiol Change TWICE per week FemSeven Sequi 50micrograms estradiol & 10micrograms levonorgestrel Change patch ONCE a week
North Yorkshire and York Menopause Guidance HRT (refer to ...
northyorkshireccg.nhs.ukTopical oestrogen for urogenital atrophy • Offer vaginal oestrogen to women with urogenital atrophy (including those on systemic HRT) and continue treatment for as long as needed to relieve symptoms. • Vagifem (10mcg vaginal tablet) or Ovestin cream0.1% are preferred options
North Yorkshire antibiotic prescribing guideline for ...
northyorkshireccg.nhs.ukAcute rhinosinusitis –avoid antibiotics, 80% resolve in 14 days without, and they only offer marginal benefit after 7 days. First line: Amoxicillin 500mg TDS for 7 days or Penicillin allergy: Doxycycline 200mg stat then 100mg OD for 7 days Acute otitis media in children –avoid antibiotics as 60% are better within 24 hours.
Subcutaneous Levetiracetam (‘Keppra’) in Palliative and ...
northyorkshireccg.nhs.ukPalliative Care Formulary 7th Edition (2020) Sutherland AE, Curtin J, Bradley V et al Subcutaneous levetiracetam for the management of seizures at the end of life. BMJ Supportive and Palliative Care 2018; 8: 129-135
Related documents
MRSA screening guidance - GOV.UK
assets.publishing.service.gov.ukshould be monitored and reported to Trust Boards and commissioners. Trusts will need to regularly review (and where necessary improve) their compliance with national screening guidance for each specialty, recent MRSA infection data, patient demographics and types of services provided within individual organisations.